Free Trial

Belite Bio (BLTE) Competitors

Belite Bio logo
$87.58 +6.32 (+7.77%)
As of 03:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BLTE vs. ELAN, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, RYTM, CRSP, and GRFS

Should you be buying Belite Bio stock or one of its competitors? The main competitors of Belite Bio include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry.

Belite Bio vs. Its Competitors

Belite Bio (NASDAQ:BLTE) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Elanco Animal Health has a net margin of 9.68% compared to Belite Bio's net margin of 0.00%. Elanco Animal Health's return on equity of 7.04% beat Belite Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Belite BioN/A -34.90% -33.56%
Elanco Animal Health 9.68%7.04%3.45%

Elanco Animal Health has higher revenue and earnings than Belite Bio. Belite Bio is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Belite BioN/AN/A-$36.14M-$1.55-56.50
Elanco Animal Health$4.48B2.27$338M$0.8623.81

0.5% of Belite Bio shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 13.3% of Belite Bio shares are held by insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Elanco Animal Health had 5 more articles in the media than Belite Bio. MarketBeat recorded 11 mentions for Elanco Animal Health and 6 mentions for Belite Bio. Belite Bio's average media sentiment score of 0.70 beat Elanco Animal Health's score of 0.61 indicating that Belite Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Belite Bio
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elanco Animal Health
4 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Belite Bio has a beta of -1.46, meaning that its stock price is 246% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500.

Belite Bio presently has a consensus price target of $96.00, suggesting a potential upside of 9.62%. Elanco Animal Health has a consensus price target of $19.14, suggesting a potential downside of 6.51%. Given Belite Bio's higher possible upside, analysts clearly believe Belite Bio is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Belite Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Elanco Animal Health
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.91

Summary

Elanco Animal Health beats Belite Bio on 13 of the 16 factors compared between the two stocks.

Get Belite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLTE vs. The Competition

MetricBelite BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.77B$3.38B$6.14B$10.45B
Dividend YieldN/A2.30%5.73%4.78%
P/E Ratio-56.1122.9585.0627.10
Price / SalesN/A428.48570.65176.64
Price / CashN/A46.1137.3961.86
Price / Book18.5510.4812.406.66
Net Income-$36.14M-$52.47M$3.32B$276.79M
7 Day Performance11.56%-0.91%-0.23%-1.40%
1 Month Performance30.90%14.63%9.56%5.64%
1 Year Performance56.44%14.38%71.76%37.04%

Belite Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLTE
Belite Bio
1.6982 of 5 stars
$87.58
+7.8%
$96.00
+9.6%
+46.5%$2.77BN/A-56.1110News Coverage
High Trading Volume
ELAN
Elanco Animal Health
2.7807 of 5 stars
$20.04
+1.4%
$19.14
-4.5%
+47.1%$9.82B$4.44B23.309,000Analyst Revision
VRNA
Verona Pharma PLC American Depositary Share
1.4602 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.2591 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+1.2%$9.02B$11.58M-10.83250Analyst Forecast
Insider Trade
ABVX
Abivax
3.0125 of 5 stars
$95.63
+2.0%
$114.25
+19.5%
+908.5%$7.30BN/A0.0061Analyst Forecast
RNA
Avidity Biosciences
2.0073 of 5 stars
$48.96
-1.6%
$68.32
+39.5%
+8.1%$7.26B$10.90M-13.75190
CYTK
Cytokinetics
3.8332 of 5 stars
$59.59
-0.7%
$76.64
+28.6%
+13.4%$7.18B$18.47M-11.68250
MRUS
Merus
0.8796 of 5 stars
$94.85
+0.5%
$93.12
-1.8%
+84.9%$7.14B$36.13M-17.2537Short Interest ↓
RYTM
Rhythm Pharmaceuticals
3.0459 of 5 stars
$100.77
0.0%
$106.64
+5.8%
+116.9%$6.70B$130.13M-33.48140Analyst Forecast
CRSP
CRISPR Therapeutics
1.6482 of 5 stars
$68.29
-6.5%
$71.71
+5.0%
+49.5%$6.65B$37.31M-12.58460News Coverage
Analyst Forecast
Insider Trade
GRFS
Grifols
3.5834 of 5 stars
$9.45
+1.4%
$10.30
+9.0%
+12.7%$6.41B$7.81B8.0823,822

Related Companies and Tools


This page (NASDAQ:BLTE) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners